Brochure
18 Oct 2024
NDSRI analysis
PDF 4.8 MB
Brightlabs has developed and validated multiple methods (GC-MS/MS & LC-MS/MS) to determine low level concentrations of Nitrosamines and NDSRIs in Drug Products
Content provided by our supplier
Brightlabs
-
NL -
2021On CPHI since
-
2Certificates
-
25 - 49Employees
Company types
Other Content from Brightlabs ()
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance